Cocrystal Pharma (COCP) Stock Statistics & Valuation Metrics

Cocrystal Pharma has a market cap or net worth of $15.86M. The enterprise value is $8.53M.

Cocrystal Pharma has 13,787,453 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cocrystal Pharma’s return on equity (ROE) is -1.39 and return on invested capital (ROIC) is -115.10%.

The current PE Ratio of Cocrystal Pharma is ―. Cocrystal Pharma’s PEG ratio is 0.02.

In the last 12 months, Cocrystal Pharma had revenue of 0.00 and earned -8.83M in profits. Earnings per share was -0.78.

In the last 12 months, operating cash flow was -8.38M and capital expenditures -12.56K, giving a free cash flow of -8.39M billion.

Cocrystal Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Cocrystal Pharma upcoming earnings date is Aug 17, 2026, TBA (Confirmed).

Cocrystal Pharma as a current ratio of 3.68, with Debt / Equity ratio of ―

In the past 12 months, Cocrystal Pharma has paid 0.00 in taxes.

Cocrystal Pharma EV to EBITDA ratio is -0.64, with an EV/FCF ratio of -0.67.

Cocrystal Pharma has $7.03M in cash and marketable securities with $1.42M in debt, giving a net cash position of $5.52M billion.

Gross margin is ―, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Cocrystal Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―